What is satiety and how does it regulate appetite?
What is satiety? Understanding the physiology of appetite regulation
Satiety is the physiological process that signals the end of a meal and maintains the feeling of fullness until the next eating occasion. Understanding how it works is essential to addressing appetite dysregulation.
Satiety, satiation, and hunger: three distinct concepts
In the physiology of eating, three terms are often confused but refer to distinct processes. Hunger is the drive to initiate food intake — a motivational state triggered by metabolic, hormonal, and environmental cues. Satiation is the process that develops during a meal and leads to its termination — it determines meal size. Satiety is the state that follows a meal and suppresses further eating until the next hunger episode — it determines inter-meal interval.
These three processes involve overlapping but distinct physiological pathways. Understanding satiety specifically — how the body signals that enough food has been consumed and maintains that perception over time — is critical for designing interventions that support appetite regulation.
Three physiological pathways working together
The perception of satiety depends on the integration of multiple signal types by the central nervous system — primarily through the brainstem (nucleus tractus solitarius) and hypothalamic feeding centers. These signals can be grouped into three major categories:
Gastric distension, abdominal wall stretch, and proprioceptive feedback from the stomach and intestines. Transmitted primarily via vagal afferents to the brainstem.
Gut hormones including GLP-1, CCK, PYY, and ghrelin modulate appetite through endocrine and paracrine pathways, acting on the hypothalamus and reward centers.
Sensory inputs (taste, smell, texture), learned associations, emotional state, and reward circuitry all influence the conscious perception of fullness and the decision to stop eating.
In healthy appetite regulation, these three signal systems work in concert. Disruption of any one pathway — or of their integration — can impair the perception of satiety and contribute to overeating.
The role of gastric distension and mechanoreceptors
Among the three signal categories, the mechanical component has been documented since the pioneering work of Paintal (1954), who identified gastric stretch receptors in the stomach wall and demonstrated their role in triggering satiation. These receptors respond to changes in gastric volume and wall tension, generating afferent signals proportional to the degree of distension.
These signals are transmitted to the central nervous system primarily through the vagus nerve. The landmark study by Phillips and Powley (1998) demonstrated that rats can detect very small changes in gastric volume (as little as 2.5 ml) and adjust their food intake accordingly — but only when vagal innervation of the stomach is intact. Complete vagotomy abolishes this ability, confirming the vagus as the critical pathway for gastric volume detection.
More recently, Bai et al. (2019) used genetic tools to identify specific populations of vagal sensory neurons innervating the gastrointestinal tract. They demonstrated that activation of mechanoreceptors — specifically intraganglionic laminar endings (IGLEs) in the stomach muscle wall — potently inhibits food intake. This finding confirmed at the cellular level what behavioral studies had long suggested: mechanical signals from the stomach are among the most powerful short-term regulators of meal size.
Extra-abdominal pressure and food intake
A critical study by Geliebter, Westreich, and Gage (1986) demonstrated that applying external pressure to the abdomen significantly alters food intake in both rats and humans. In their experiments, extra-abdominal pressure increased intragastric pressure, reduced gastric emptying rate, and decreased the volume of food consumed. This was one of the first experimental demonstrations that mechanical signals relevant to satiety can be modulated from outside the body.
GLP-1 and the neuroendocrine regulation of appetite
The hormonal regulation of appetite involves a complex interplay of gut-derived peptides, each acting on distinct receptors and timescales. Among the most clinically relevant is GLP-1 (glucagon-like peptide 1), an incretin hormone released by intestinal L-cells in response to nutrient ingestion.
GLP-1 acts on multiple targets: it enhances insulin secretion, slows gastric emptying, and — critically for appetite regulation — signals to the hypothalamus and brainstem to reduce food intake and promote satiety. The clinical success of GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) in obesity management has powerfully demonstrated the therapeutic potential of targeting hormonal satiety pathways.
Limitations of the hormonal approach alone
Despite their efficacy, GLP-1 therapies present well-documented challenges: effects are closely linked to continued treatment, with appetite returning upon discontinuation. Individual response is variable, tolerability issues (nausea, GI side effects) can limit adherence, and long-term sustainability remains a question in chronic weight management.
These limitations do not diminish the value of GLP-1 therapies — they highlight the complexity of appetite regulation and the potential benefit of multi-pathway strategies that combine hormonal, behavioral, and mechanical approaches.
Read more: GASTER control® and GLP-1 therapiesWhy some individuals struggle to recognize fullness
In many individuals with overweight or obesity, the perception of satiety signals appears to be altered. This is not simply a matter of willpower or behavioral discipline — it reflects measurable changes in the physiological systems that regulate appetite.
Reduced mechanical sensitivity
Chronic overeating can lead to gastric accommodation — an increase in the resting volume of the stomach that requires larger food volumes to trigger the same level of distension. The mechanical threshold for satiation rises, and individuals may consistently eat beyond their metabolic needs before perceiving fullness.
Hormonal dysregulation
Alterations in gut hormone secretion (reduced GLP-1 response, elevated ghrelin, diminished PYY) can weaken the post-meal satiety signal. In some individuals, the hormonal braking system that should terminate a meal and maintain inter-meal satiety is insufficiently activated.
Cognitive and emotional override
Stress, emotional eating, disinhibited eating patterns, and environmental food cues can override physiological satiety signals. The neural circuits that process food reward can dominate over the homeostatic systems that regulate energy balance — leading to eating beyond satiety.
An under-explored pathway in clinical practice
While pharmacological approaches (GLP-1 agonists) and surgical approaches (bariatric surgery, intragastric balloons) have been extensively developed, the mechanical component of satiety has received comparatively little clinical attention as a therapeutic lever.
Yet the scientific evidence is clear: mechanical signals — particularly gastric distension and abdominal wall mechanosensitivity — play a fundamental role in meal termination and satiety perception. The work of Paintal, Phillips, Powley, Bai, and Geliebter collectively demonstrates that these signals are potent, vagally mediated, and — critically — modulable from outside the body.
This opens a compelling question: could a non-invasive, mechanical approach to satiety perception offer a useful complement to existing pharmacological and behavioral strategies?
Several characteristics make the mechanical pathway particularly attractive as a clinical target: it is immediate (mechanical signals arrive at the brainstem within seconds of distension), it is dose-responsive (the signal scales with the degree of compression or distension), it is non-pharmacological (no drug interactions, no systemic effects), and it is reversible (the effect ceases when the mechanical stimulus is removed).
Exploring mechanical modulation of satiety perception
Based on the physiological principles described above, approaches targeting the mechanical component of satiety are beginning to be explored in clinical settings. The rationale is grounded in the convergent evidence from decades of research on gastric mechanosensitivity and vagal afferent signaling.
GASTER control® represents one such approach: a non-invasive device applying controlled external abdominal compression to the epigastric region, designed to interact with the mechanical conditions of satiety signal expression. It does not create satiety — it modulates the conditions in which satiety is perceived.
This approach is currently under clinical evaluation. Exploratory data suggest consistent behavioral effects (earlier satiety perception, spontaneous portion reduction), and a multicentric observational registry is underway to further characterize outcomes.
Learn about the technology behind GASTER control®See current clinical evidence
Key literature on satiety physiology
The understanding of satiety presented on this page draws on established peer-reviewed research spanning over seven decades of investigation into gastric mechanosensitivity, vagal signaling, and appetite regulation.
GASTER control® — GASTER Technology Limited, 5/1 Merchants Street, Valletta VLT 1171, Malta.